GFACX
Price
$74.83
Change
+$0.34 (+0.46%)
Updated
Sep 29 closing price
Net Assets
336.88B
RMBGX
Price
$37.67
Change
+$0.04 (+0.11%)
Updated
Sep 29 closing price
Net Assets
115.36M
Interact to see
Advertisement

GFACX vs RMBGX

Header iconGFACX vs RMBGX Comparison
Open Charts GFACX vs RMBGXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.83
Change+$0.34 (+0.46%)
VolumeN/A
Net Assets336.88B
RMB I
Price$37.67
Change+$0.04 (+0.11%)
VolumeN/A
Net Assets115.36M
GFACX vs RMBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. RMBGX commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RMBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 337B vs. RMBGX (115M). RMBGX pays higher dividends than GFACX: RMBGX (0.10) vs GFACX (0.00). GFACX was incepted earlier than RMBGX: GFACX (25 years) vs RMBGX (9 years). GFACX (1.36) is less costly to investors than RMBGX (0.99). GFACX is a more actively managed with annual turnover of: 25.00 vs. RMBGX (10.00). GFACX has a lower initial minimum investment than RMBGX: GFACX (250) vs RMBGX (100000). GFACX annual gain was more profitable for investors over the last year : 10.95 vs. RMBGX (0.96). GFACX (35.26) and RMBGX (34.25) have equivalent 5 years return.
GFACXRMBGXGFACX / RMBGX
Total Expense Ratio1.360.99137%
Annual Report Gross Expense Ratio1.360.99137%
Fund Existence25 years9 years-
Gain YTD16.8297.269232%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets337B115M293,043%
Annual Yield % from dividends0.000.10-
Returns for 1 year10.950.961,144%
Returns for 3 years67.3230.80219%
Returns for 5 years35.2634.25103%
Returns for 10 years85.81N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA3.440.04
+1.03%
Arcadia Biosciences
EQV10.39N/A
N/A
EQV Ventures Acquisition Corp
SWKS76.93-2.58
-3.24%
Skyworks Solutions
COEP16.51-0.99
-5.66%
Coeptis Therapeutics Holdings Inc
NN14.78-0.95
-6.04%
NextNav